Overall, GAL’s multifaceted anti-inflammatory actions, including NF-κB inhibition, cytokine reduction, MMP control, and Nrf2 activation, position it as a promising therapy for RA. This evidence concerns the gene NFKB1 and rheumatoid arthritis.